The aim of this study is to determine if the use of Nasal high flow in patients with exacerbation COPD and/of pneumonia gives more comfort and a faster recovery then regular oxygen therapy
ID
Source
Brief title
Condition
- Lower respiratory tract disorders (excl obstruction and infection)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primaire parameter is comfort. we ask patients to complete CCQ daily during
admittion.
Secondary outcome
Besides the primaire parameter, there will also measurements to investigate
cough, dyspnea, oxygenation, respiration, heartfrequency, viscocity of the
mucus and duration of admittion
Background summary
Patients admitted on the lungward have different lungproblems, with oxgenation
problems as the result. This is treated with oxygen therapy. There are several
methods of administration oxygen. Most commonly used is a tube under the
nostrils applying oxygen. The Nasal high flow is also used for a numbre of
years now, but only with patients with higher oxygen needs. This application
has multiple benefits. Eg: heated and humidified oxygen and a higher flow
Study objective
The aim of this study is to determine if the use of Nasal high flow in patients
with exacerbation COPD and/of pneumonia gives more comfort and a faster
recovery then regular oxygen therapy
Study design
This is a randomized intervention study. Patients are randomized into 2 groups.
Patients in the intervention group receive oxygen therapy by the nasal high
flow. The control gropu receive oxygen by the regular oxygen application.
Intervention
Nasal high flow oxygen therapy
Study burden and risks
Patients are asked to complete different questionaires daily. These
questionnaires are not burdensome. Patients in the intervention group use
oxygen by nasal high flow. This is safely used in other wards and other
patients on the lungward. This application is safe and there is no additional
risk.
koekoekslaan 1
Nieuwegein 3435CM
NL
koekoekslaan 1
Nieuwegein 3435CM
NL
Listed location countries
Age
Inclusion criteria
exacerbation COPD and/or pneumonia
admitted on the lung ward
using oxygen, no less than 1 litre/minute
Exclusion criteria
acute hypercapnia or acidosis,
pneumothorax
delirium
domestic use of Bi-pap or C-pap
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL71035.100.19 |